Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $52.09 million. The enterprise value is $76.08 million.
Important Dates
The last earnings date was Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 9.45 million shares outstanding. The number of shares has increased by 63.95% in one year.
| Current Share Class | 9.45M |
| Shares Outstanding | 9.45M |
| Shares Change (YoY) | +63.95% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 60.33% |
| Owned by Institutions (%) | 7.45% |
| Float | 1.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.97 |
| Forward PS | 4.11 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26
| Current Ratio | 1.26 |
| Quick Ratio | 1.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.18 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -51.93% |
| Return on Invested Capital (ROIC) | -86.95% |
| Return on Capital Employed (ROCE) | -382.91% |
| Revenue Per Employee | $207,099 |
| Profits Per Employee | -$684,507 |
| Employee Count | 71 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 3.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.22% in the last 52 weeks. The beta is 1.92, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | -81.22% |
| 50-Day Moving Average | 6.63 |
| 200-Day Moving Average | 6.69 |
| Relative Strength Index (RSI) | 38.26 |
| Average Volume (20 Days) | 45,395 |
Short Selling Information
The latest short interest is 149,764, so 1.59% of the outstanding shares have been sold short.
| Short Interest | 149,764 |
| Short Previous Month | 2.21M |
| Short % of Shares Out | 1.59% |
| Short % of Float | 7.74% |
| Short Ratio (days to cover) | 2.07 |
Income Statement
In the last 12 months, VRCA had revenue of $14.70 million and -$48.60 million in losses. Loss per share was -$6.40.
| Revenue | 14.70M |
| Gross Profit | 5.01M |
| Operating Income | -37.85M |
| Pretax Income | -80.74M |
| Net Income | -48.60M |
| EBITDA | -37.15M |
| EBIT | -37.85M |
| Loss Per Share | -$6.40 |
Full Income StatementBalance Sheet
The company has $15.40 million in cash and $38.89 million in debt, giving a net cash position of -$23.50 million or -$2.49 per share.
| Cash & Cash Equivalents | 15.40M |
| Total Debt | 38.89M |
| Net Cash | -23.50M |
| Net Cash Per Share | -$2.49 |
| Equity (Book Value) | -17.48M |
| Book Value Per Share | -1.89 |
| Working Capital | 7.56M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$47.34 million and capital expenditures -$16,000, giving a free cash flow of -$47.36 million.
| Operating Cash Flow | -47.34M |
| Capital Expenditures | -16,000 |
| Free Cash Flow | -47.36M |
| FCF Per Share | -$5.01 |
Full Cash Flow StatementMargins
| Gross Margin | 34.07% |
| Operating Margin | -257.42% |
| Pretax Margin | -330.52% |
| Profit Margin | n/a |
| EBITDA Margin | -252.65% |
| EBIT Margin | -257.42% |
| FCF Margin | n/a |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -63.95% |
| Shareholder Yield | -63.95% |
| Earnings Yield | -92.42% |
| FCF Yield | -90.06% |
Analyst Forecast
The average price target for VRCA is $60.00, which is 987.94% higher than the current price. The consensus rating is "Hold".
| Price Target | $60.00 |
| Price Target Difference | 987.94% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 105.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 25, 2025. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jul 25, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
VRCA has an Altman Z-Score of -12.94 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.94 |
| Piotroski F-Score | 4 |
